Private profits versus public policy : the pharmaceutical industry and the Canadian state / Joel Lexchin.

Format:

Book

Author/Creator:

Lexchin, Joel, 1948- author.

Language:

English

Subjects (All):

Pharmaceutical industry--Government policy--Canada.

Pharmaceutical industry.

Drug development--Government policy--Canada.

Drug development.

Prescription pricing--Government policy--Canada.

Prescription pricing.

Profit--Government policy--Canada.

Profit.

Profit--Government policy.

Prescription pricing--Government policy.

Government policy.

Pharmaceutical industry--Government policy.

Canada.

Physical Description:

xix, 364 pages : illustrations ; 24 cm

Place of Publication:

Toronto ; Buffalo ; London : University of Toronto Press, [2016]

Summary:

"The widespread condemnation of drastic price increases on life-saving drugs highlights our growing dependency on and vulnerability to international pharmaceutical conglomerates. However, aren't the interests of the public supposed to supersede the pursuit of private profit? In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century. Although the Canadian government is supposed to regulate the industry to serve the needs of public health, waves of deregulatory reforms and intellectual property rights legislation have shifted the balance of power in favour of these companies' quest for profit. Joel Lexchin offers a series of recommendations to tip the scale back in the public's favour. This enlightening work is the first book that deals exclusively with the pharmaceutical industry in Canada in over thirty years."-- Provided by publisher.

Contents:

1 (De)regulation through cooperation 13

2 Biased testing, hidden results, and the regulation of clinical trials 34

3 Approving new drugs: Better or just more? 54

4 Regulating promotion or licensing deception? 81

5 Health Canada and drug safety: How safe are we? 112

6 Is intellectual property a right? 135

7 How revenue is generated: Prices, volume, mix, and overall spending 157

8 Who gets the value from research and development? 184

9 Canada, the pharmaceutical industry, and access to medicines in the Global South 208

10 Courage, my friends; 'tis not too late to build a better world 225.

Notes:

Includes bibliographical references (pages 261-330) and index.

ISBN:

9781442649170

1442649178

9781442626591

1442626593

OCLC:

950057142